Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Sepiso K Masenga"'
Autor:
Emmanuel L Luwaya, Lackson Mwape, Kaole Bwalya, Chileleko Siakabanze, Benson M Hamooya, Sepiso K Masenga
Publikováno v:
PLoS ONE, Vol 19, Iss 9, p e0308869 (2024)
BackgroundAn increase in the prevalence of HIV drug resistance (HIVDR) has been reported in recent years, especially in persons on non-nucleoside reverse transcriptase inhibitors (NNRTIs) due to their low genetic barrier to mutations. However, there
Externí odkaz:
https://doaj.org/article/e3d7db92f9244431be36a5f51d5b0d37
Autor:
Lweendo Muchaili, Precious Simushi, Bislom C Mweene, Tuku Mwakyoma, Sepiso K Masenga, Benson M Hamooya
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0299963 (2024)
BackgroundHuman papillomavirus (HPV) infection is strongly associated with cervical cancer with almost all cases being associated with the infection. Cervical cancer is the leading cause of cancer death among women in Zambia and the fourth leading ca
Externí odkaz:
https://doaj.org/article/1a376a35ef47434fa2c25f4ff21f7a1b
Publikováno v:
PLoS ONE, Vol 18, Iss 12, p e0295401 (2023)
BackgroundHypertension has in the recent past surfaced as one of the conditions that has a significant impact on workforce productivity in emerging economies. Zambia is no different and has in the recent past recorded increasing cases. Despite the im
Externí odkaz:
https://doaj.org/article/d5efa8d12fcf42bdbd0a54f9ce4bcbc8
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0264650 (2022)
BackgroundSalt impairs endothelial function and increases arterial stiffness independent of blood pressure. The mechanisms are unknown. Recent evidence suggests that there is a possible link between salt consumption and sodium buffering capacity and
Externí odkaz:
https://doaj.org/article/f56360d0d3fc4c3ca6b67e1ccdb75133
Autor:
Benson M Hamooya, Patrick Musonda, Wilbroad Mutale, Sepiso K Masenga, Hikabasa Halwiindi, Katongo H Mutengo, Kaseya O R Chiyeñu, Gershom Chongwe, John R Koethe, Loren Lipworth, Douglas C Heimburger
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247004 (2021)
BackgroundWith the introduction of effective antiretroviral therapy (ART), people living with HIV (PLWH) are surviving longer and are at risk for developing metabolic abnormalities that contribute to cardiovascular disease (CVD). In Sub-Saharan Afric
Externí odkaz:
https://doaj.org/article/66c2f0a5cebd4f26aa601608bc9cc41f
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Hypertension is a risk factor for end organ damage and death and is more common in persons with HIV compared to the general population. Several mechanisms have been studied in the pathogenesis of hypertension. Current evidence suggests that the epith
Externí odkaz:
https://doaj.org/article/a30f2b65b3f248db8d2b5dfb651b9c20
Publikováno v:
Current Hypertension Reports. 25:25-33
Autor:
Sepiso K. Masenga, Fernando Elijovich, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, Sody M. Munsaka, Shilin Zhao, John R. Koethe, Annet Kirabo
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 4 (2020)
Background People living with HIV (PLWH) are at increased risk of cardiovascular disease, including hypertension, which persists despite effective plasma viral suppression on antiretroviral therapy. HIV infection is characterized by long‐term alter
Externí odkaz:
https://doaj.org/article/006518eed26e4332b2e968311bf122d7
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-4 (2017)
Abstract Background Since the recent introduction of GeneXepert for the detection of Tuberculosis (TB) drug resistance mutations in both primary resistance and acquired resistance in Zambia, little has been documented in literature on the issue of ri
Externí odkaz:
https://doaj.org/article/eda1778e324f49abb997decc3b150c55
Publikováno v:
Medical Journal of Zambia. 49:4-16
Background: Persons living with HIV (PLWH) are more likely to develop hypertension and cardiovascular disease than the HIV-negative population. The new hypertension guidelines by the American Heart Association (AHA) and the American College of Cardio